Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST)
2012-01-01 Boni, C; Tiseo, M; Boni, L; Baldini, E; Recchia, F; Barone, C; Grossi, F; Germano, D; Matano, E; Marini, G; Labianca, R; Di Costanzo, F; Bagnulo, A; Pennucci, C; Caroti, C; Mencoboni, M; Zanelli, F; Prochilo, T; Cafferata, Ma; Ardizzoni, A
Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma
2006-01-01 Ceresoli, Gl; Zucali, Pa; Favaretto, Ag; Grossi, F; Bidoli, P; Del Conte, G; Ceribelli, A; Bearz, A; Morenghi, E; Cavina, R; Marangolo, M; Parra, Hjs; Santoro, A
Informal caregiving burden in advanced non-small cell lung cancer: The HABIT study
2007-01-01 Gridelli, C; Ferrara, C; Guerriero, C; Palazzo, S; Grasso, G; Pavese, I; Satta, F; Bajetta, E; Cortinovis, D; Barbieri, F; Gebbia, V; Grossi, F; Novello, S; Baldini, E; Gasparini, G; Latino, W; Durante, E; Giustini, L; Negrini, C
Simple posterior elbow dislocations: Conservative management and role of ulnar-bone coverage angle
2021-01-01 Fozzato, S.; Marin, R.; Basilico, M.; Surace, M. F.
[Acute myocarditis in a young adult two days after Pfizer vaccination]
2021-01-01 Facetti, Sara; Giraldi, Mario; Vecchi, Andrea Lorenzo; Rogiani, Silvia; Nassiacos, Daniele
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50%
2020-01-01 Cortellini, A.; Tiseo, M.; Banna, G. L.; Cappuzzo, F.; Aerts, J. G. J. V.; Barbieri, F.; Giusti, R.; Bria, E.; Cortinovis, D.; Grossi, F.; Migliorino, M. R.; Galetta, D.; Passiglia, F.; Santini, D.; Berardi, R.; Morabito, A.; Genova, C.; Mazzoni, F.; Di Noia, V.; Signorelli, D.; Tuzi, A.; Gelibter, A.; Marchetti, P.; Macerelli, M.; Rastelli, F.; Chiari, R.; Rocco, D.; Gori, S.; De Tursi, M.; Mansueto, G.; Zoratto, F.; Santoni, M.; Tudini, M.; Rijavec, E.; Filetti, M.; Catino, A.; Pizzutilo, P.; Sala, L.; Citarella, F.; Marco, R.; Torniai, M.; Cantini, L.; Targato, G.; Sforza, V.; Nigro, O.; Ferrara, M. G.; D'Argento, E.; Buti, S.; Bordi, P.; Antonuzzo, L.; Scodes, S.; Landi, L.; Guaitoli, G.; Baldessari, C.; Della Gravara, L.; Dal Bello, M. G.; Belderbos, R. A.; Bironzo, P.; Carnio, S.; Ricciardi, S.; Grieco, A.; De Toma, A.; Proto, C.; Friedlaender, A.; Cantale, O.; Ricciuti, B.; Addeo, A.; Metro, G.; Ficorella, C.; Porzio, G.
Prognostic and Therapeutic Implications of MicroRNA in Malignant Pleural Mesothelioma
2016-01-01 Truini, A; Coco, S; Genova, C; Mora, M; Dal Bello, Mg; Vanni, I; Alama, A; Rijavec E, ; Barletta, G; Biello, F; Maggioni, C; Grossi, F
Evaluation of CTLA-4 expression and relevance as a novel prognostic factor in patients with non-small cell lung cancer
2012-01-01 Salvi, S; Fontana, V; Boccardo, S; Merlo, Df; Margallo, E; Laurent, S; Morabito, A; Rijavec, E; Dal Bello, Mg; Mora, M; Ratto, Gb; Grossi, F; Truini, M; Pistillo, Mp
Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial
2016-01-01 Schuler, M; Yang, Jc; Park, K; Kim, Jh; Bennouna, J; Chen, Ym; Chouaid, C; De Marinis, F; Feng, Jf; Grossi, F; Kim, Dw; Liu, X; Lu, S; Strausz, J; Vinnyk, Y; Wiewrodt, R; Zhou, C; Wang, B; Chand, Vk; Planchard, D; LUX-Lung, 5 Investigators
Buccal mucosa cells as in vivo model to evaluate gefitinib activity in patients with advanced non-small cell lung cancer
2007-01-01 Loprevite, M; Tiseo, M; Chiaramondia, M; Capelletti, M; Bozzetti, C; Bortesi, B; Naldi, N; Nizzoli, R; Dadati, P; Kunkl, A; Zennaro, D; Lagrasta, C; Campanini, N; Spiritelli, E; Camisa, R; Grossi, F; Rindi, G; Franciosi, V; Ardizzoni, A
Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials
2008-01-01 Ceresoli, Gl; Castagneto, B; Zucali, Pa; Favaretto, A; Mencoboni, M; Grossi, F; Cortinovis, D; Del Conte, G; Ceribelli, A; Bearz, A; Salamina, S; De Vincenzo, F; Cappuzzo, F; Marangolo, M; Torri, V; Santoro, A
Low-dose computed tomography screening for lung cancer and pleural mesothelioma in an asbestos-exposed population: Baseline results of a prospective, nonrandomized feasibility trial - An alpe-adria thoracic oncology multidisciplinary group study (ATOM 002)
2007-01-01 Fasola, G; Belvedere, O; Aita, M; Zanin, T; Follador, A; Cassetti, P; Meduri, S; De Pangher, V; Pignata, G; Rosolen, V; Barbone, F; Grossi, F
Impact of Third-Generation Drugs on the Activity of First-Line Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Meta-Analytical Approach
2009-01-01 Grossi, F; Aita, M; Defferrari, C; Rosetti, F; Brianti, A; Fasola, G; Vinante, O; Pronzato, P; Pappagallo, G
The activity of raltitrexed (Tomudex (R)) in malignant pleural mesothelioma: an EORTC phase II study (08992)
2003-01-01 Baas, P; Ardizzoni, A; Grossi, F; Nackaerts, K; Numico, G; Van Marck, E; van de Vijver, M; Monetti, F; Smid-Geirnaerdt, Mja; van Zandwijk, N; Debruyne, C; Legrand, C; Giaccone, G
Efficacy of motesanib diphosphate in non-small-cell lung cancer
2014-01-01 Rijavec, E; Genova, C; Barletta, G; Biello, F; Dal Bello, Mg; Coco, S; Truini, A; Vanni, I; Alama, A; Boccardo, F; Grossi, F
To treat or not to treat advanced non-small-cell lung cancer patients with impaired performance status?
2005-01-01 Belvedere, O; Grossi, F
Tumor measurements on computed tomographic images of non-small cell lung cancer were similar among cancer professionals from different specialties
2004-01-01 Grossi, F; Belvedere, O; Fasola, G; Ceschia, T; Meduri, S; Sibau, A; Sacco, C; Bazzocchi, M; Talmassons, G; Morelli, A; Barbone, F; Sobrero, A
Clinical evidence for second- and third-line treatment options in advanced non-small cell lung cancer
2008-01-01 de Marinisa, F; Grossi, F
Evaluation of antitumor activity using change in tumor size of the survivin antisense oligonucleotide LY2181308 in combination with docetaxel for second-line treatment of patients with non-small-cell lung cancer: a randomized open-label phase II study
2014-01-01 Natale, R; Blackhall, F; Kowalski, D; Ramlau, R; Bepler, G; Grossi, F; Lerchenmüller, C; Pinder-Schenck, M; Mezger, J; Danson, S; Gadgeel, Sm; Summers, Y; Callies, S; André, V; Das, M; Lahn, M; Talbot, D
Informal caregiving burden in advance non-small cell lung cancer: The HABIT study (vol 2, pg 475, 2007)
2007-01-01 Gridelli, C; Ferrara, C; Guerriero, C; Palazzo, S; Grasso, G; Pavese, I; Salta, F; Bajetta, E; Cortinovis, D; Barbieri, F; Gebbia, V; Grossi, F; Novello, S; Baldini, E; Gasparini, G; Latino, W; Durante, E; Giustini, L; Negrini, C
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST) | 1-gen-2012 | Boni, C; Tiseo, M; Boni, L; Baldini, E; Recchia, F; Barone, C; Grossi, F; Germano, D; Matano, E; Marini, G; Labianca, R; Di Costanzo, F; Bagnulo, A; Pennucci, C; Caroti, C; Mencoboni, M; Zanelli, F; Prochilo, T; Cafferata, Ma; Ardizzoni, A | |
| Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma | 1-gen-2006 | Ceresoli, Gl; Zucali, Pa; Favaretto, Ag; Grossi, F; Bidoli, P; Del Conte, G; Ceribelli, A; Bearz, A; Morenghi, E; Cavina, R; Marangolo, M; Parra, Hjs; Santoro, A | |
| Informal caregiving burden in advanced non-small cell lung cancer: The HABIT study | 1-gen-2007 | Gridelli, C; Ferrara, C; Guerriero, C; Palazzo, S; Grasso, G; Pavese, I; Satta, F; Bajetta, E; Cortinovis, D; Barbieri, F; Gebbia, V; Grossi, F; Novello, S; Baldini, E; Gasparini, G; Latino, W; Durante, E; Giustini, L; Negrini, C | |
| Simple posterior elbow dislocations: Conservative management and role of ulnar-bone coverage angle | 1-gen-2021 | Fozzato, S.; Marin, R.; Basilico, M.; Surace, M. F. | |
| [Acute myocarditis in a young adult two days after Pfizer vaccination] | 1-gen-2021 | Facetti, Sara; Giraldi, Mario; Vecchi, Andrea Lorenzo; Rogiani, Silvia; Nassiacos, Daniele | |
| Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50% | 1-gen-2020 | Cortellini, A.; Tiseo, M.; Banna, G. L.; Cappuzzo, F.; Aerts, J. G. J. V.; Barbieri, F.; Giusti, R.; Bria, E.; Cortinovis, D.; Grossi, F.; Migliorino, M. R.; Galetta, D.; Passiglia, F.; Santini, D.; Berardi, R.; Morabito, A.; Genova, C.; Mazzoni, F.; Di Noia, V.; Signorelli, D.; Tuzi, A.; Gelibter, A.; Marchetti, P.; Macerelli, M.; Rastelli, F.; Chiari, R.; Rocco, D.; Gori, S.; De Tursi, M.; Mansueto, G.; Zoratto, F.; Santoni, M.; Tudini, M.; Rijavec, E.; Filetti, M.; Catino, A.; Pizzutilo, P.; Sala, L.; Citarella, F.; Marco, R.; Torniai, M.; Cantini, L.; Targato, G.; Sforza, V.; Nigro, O.; Ferrara, M. G.; D'Argento, E.; Buti, S.; Bordi, P.; Antonuzzo, L.; Scodes, S.; Landi, L.; Guaitoli, G.; Baldessari, C.; Della Gravara, L.; Dal Bello, M. G.; Belderbos, R. A.; Bironzo, P.; Carnio, S.; Ricciardi, S.; Grieco, A.; De Toma, A.; Proto, C.; Friedlaender, A.; Cantale, O.; Ricciuti, B.; Addeo, A.; Metro, G.; Ficorella, C.; Porzio, G. | |
| Prognostic and Therapeutic Implications of MicroRNA in Malignant Pleural Mesothelioma | 1-gen-2016 | Truini, A; Coco, S; Genova, C; Mora, M; Dal Bello, Mg; Vanni, I; Alama, A; Rijavec E, ; Barletta, G; Biello, F; Maggioni, C; Grossi, F | |
| Evaluation of CTLA-4 expression and relevance as a novel prognostic factor in patients with non-small cell lung cancer | 1-gen-2012 | Salvi, S; Fontana, V; Boccardo, S; Merlo, Df; Margallo, E; Laurent, S; Morabito, A; Rijavec, E; Dal Bello, Mg; Mora, M; Ratto, Gb; Grossi, F; Truini, M; Pistillo, Mp | |
| Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial | 1-gen-2016 | Schuler, M; Yang, Jc; Park, K; Kim, Jh; Bennouna, J; Chen, Ym; Chouaid, C; De Marinis, F; Feng, Jf; Grossi, F; Kim, Dw; Liu, X; Lu, S; Strausz, J; Vinnyk, Y; Wiewrodt, R; Zhou, C; Wang, B; Chand, Vk; Planchard, D; LUX-Lung, 5 Investigators | |
| Buccal mucosa cells as in vivo model to evaluate gefitinib activity in patients with advanced non-small cell lung cancer | 1-gen-2007 | Loprevite, M; Tiseo, M; Chiaramondia, M; Capelletti, M; Bozzetti, C; Bortesi, B; Naldi, N; Nizzoli, R; Dadati, P; Kunkl, A; Zennaro, D; Lagrasta, C; Campanini, N; Spiritelli, E; Camisa, R; Grossi, F; Rindi, G; Franciosi, V; Ardizzoni, A | |
| Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials | 1-gen-2008 | Ceresoli, Gl; Castagneto, B; Zucali, Pa; Favaretto, A; Mencoboni, M; Grossi, F; Cortinovis, D; Del Conte, G; Ceribelli, A; Bearz, A; Salamina, S; De Vincenzo, F; Cappuzzo, F; Marangolo, M; Torri, V; Santoro, A | |
| Low-dose computed tomography screening for lung cancer and pleural mesothelioma in an asbestos-exposed population: Baseline results of a prospective, nonrandomized feasibility trial - An alpe-adria thoracic oncology multidisciplinary group study (ATOM 002) | 1-gen-2007 | Fasola, G; Belvedere, O; Aita, M; Zanin, T; Follador, A; Cassetti, P; Meduri, S; De Pangher, V; Pignata, G; Rosolen, V; Barbone, F; Grossi, F | |
| Impact of Third-Generation Drugs on the Activity of First-Line Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Meta-Analytical Approach | 1-gen-2009 | Grossi, F; Aita, M; Defferrari, C; Rosetti, F; Brianti, A; Fasola, G; Vinante, O; Pronzato, P; Pappagallo, G | |
| The activity of raltitrexed (Tomudex (R)) in malignant pleural mesothelioma: an EORTC phase II study (08992) | 1-gen-2003 | Baas, P; Ardizzoni, A; Grossi, F; Nackaerts, K; Numico, G; Van Marck, E; van de Vijver, M; Monetti, F; Smid-Geirnaerdt, Mja; van Zandwijk, N; Debruyne, C; Legrand, C; Giaccone, G | |
| Efficacy of motesanib diphosphate in non-small-cell lung cancer | 1-gen-2014 | Rijavec, E; Genova, C; Barletta, G; Biello, F; Dal Bello, Mg; Coco, S; Truini, A; Vanni, I; Alama, A; Boccardo, F; Grossi, F | |
| To treat or not to treat advanced non-small-cell lung cancer patients with impaired performance status? | 1-gen-2005 | Belvedere, O; Grossi, F | |
| Tumor measurements on computed tomographic images of non-small cell lung cancer were similar among cancer professionals from different specialties | 1-gen-2004 | Grossi, F; Belvedere, O; Fasola, G; Ceschia, T; Meduri, S; Sibau, A; Sacco, C; Bazzocchi, M; Talmassons, G; Morelli, A; Barbone, F; Sobrero, A | |
| Clinical evidence for second- and third-line treatment options in advanced non-small cell lung cancer | 1-gen-2008 | de Marinisa, F; Grossi, F | |
| Evaluation of antitumor activity using change in tumor size of the survivin antisense oligonucleotide LY2181308 in combination with docetaxel for second-line treatment of patients with non-small-cell lung cancer: a randomized open-label phase II study | 1-gen-2014 | Natale, R; Blackhall, F; Kowalski, D; Ramlau, R; Bepler, G; Grossi, F; Lerchenmüller, C; Pinder-Schenck, M; Mezger, J; Danson, S; Gadgeel, Sm; Summers, Y; Callies, S; André, V; Das, M; Lahn, M; Talbot, D | |
| Informal caregiving burden in advance non-small cell lung cancer: The HABIT study (vol 2, pg 475, 2007) | 1-gen-2007 | Gridelli, C; Ferrara, C; Guerriero, C; Palazzo, S; Grasso, G; Pavese, I; Salta, F; Bajetta, E; Cortinovis, D; Barbieri, F; Gebbia, V; Grossi, F; Novello, S; Baldini, E; Gasparini, G; Latino, W; Durante, E; Giustini, L; Negrini, C |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- Articoli su Riviste30447
Data di pubblicazione
- In corso di stampa28
- 2020 - 20246329
- 2010 - 201911332
- 2000 - 20097788
- 1990 - 19993550
- 1980 - 19891160
- 1970 - 1979252
- 1967 - 19698
Editore
- Edizioni Luigi Pozzi Srl:via Pana...51
- Japadre Editore, L'Aquila36
- WILEY34
- Elsevier BV:PO Box 211, 1000 AE A...31
- ELSEVIER SCIENCE BV29
- Franco Angeli Riviste SRL:viale M...28
- Springer Verlag Germany:Tiergarte...28
- -Roma: [s.n.]. -Artegierre-Esseze...26
- Elsevier B.V.23
- Royal Society of Chemistry:Thomas...21
Rivista
- PHYSICAL REVIEW LETTERS212
- LA RADIOLOGIA MEDICA173
- NUCLEAR INSTRUMENTS & METHODS IN ...169
- PHYSICS LETTERS. SECTION B152
- MONTHLY NOTICES OF THE ROYAL ASTR...140
- PHYSICAL REVIEW A140
- THROMBOSIS AND HAEMOSTASIS139
- PLOS ONE130
- IL PROTAGORA124
- SCIENTIFIC REPORTS117
Serie
- PROCEEDINGS OF INTERNATIONAL MATH...1
Keyword
- Humans1562
- Female778
- Male657
- Middle Aged497
- Aged456
- Adult440
- COVID-19420
- Italy304
- SARS-CoV-2257
- Treatment Outcome234
Lingua
- eng14850
- ita2365
- fre49
- spa48
- ger32
- por14
- rus8
- bul7
- gre4
- chi2
Accesso al fulltext
- no fulltext24019
- reserved3335
- open2935
- partially open73
- restricted73
- embargoed7
- mixed5